Changing Physician Prescribing Behavior: The Community-Acquired Pneumonia Intervention Trial

Kim C. Coley, Susan J. Skledar , Michael J. Fine, Donald M. Yealy , Patrick P. Gleason , Michael L. Ryan, Wishwa Kapoor , and Robert A. Branch


Am J Health Syst Pharm. 2000;57(16) 

In This Article


A multifaceted intervention program designed to change antimicrobial prescribing for CAP by encouraging the use of cefuroxime with or without erythromycin effectively altered prescribing behavior and reduced antimicrobial costs without compromising patient outcomes.

[a] The four PORT study sites were Massachusetts General Hospital, Boston; Victoria General Hospital, Halifax, Nova Scotia; St. Francis Hospital, Pittsburgh; and University of Pittsburgh Medical Center, Pittsburgh.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.